Research / ANGI / Fundamental state Inspectable configuration
State dimensions Filing 0001705110-23-000040 General Corporate
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.02% · OPTIONAL · VALID
Operating cash generation 40th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
4.86% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.revenue
-10.03% · CORE · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
89.29% · CORE · NOT_ENOUGH_HISTORY
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-2.67% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.45% · OPTIONAL · VALID
SBC intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.28% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 31 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 6/6 normalized Level 3 Mar 31, 2022 6/6 normalized Level 3 Jun 30, 2022 6/7 normalized Level 3 Sep 30, 2022 6/7 normalized Level 3 Dec 31, 2022 6/7 normalized Level 3 Mar 31, 2023 6/7 normalized Level 3 Jun 30, 2023 6/7 normalized Level 3 Sep 30, 2023 6/7 normalized Level 3 Dec 31, 2023 5/6 normalized Level 3 Mar 31, 2024 5/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 6/6 normalized Level 3 Dec 31, 2024 6/6 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 6/6 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 6.15%
Current 3.02%
Delta -3.13% Cash Generation Increased
Previous 1.43%
Current 4.86%
Delta 3.43% Growth Decreased
Previous 12.23%
Current -10.03%
Delta -22.26% Margin Increased
Previous 76.84%
Current 89.29%
Delta 12.45% Profitability Increased
Previous -6.68%
Current -2.67%
Delta 4.01% R And D Intensity Increased
Previous 3.90%
Current 6.45%
Delta 2.55% Sbc Intensity Increased
Previous 2.78%
Current 3.28%
Delta 0.50% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.